The KEAP1-mediated repression of NRF2 activity is critical for our bodies, as indicated by the targeted deletion of KEAP1 in mice resulting in lethal hyperkeratosis in the upper digestive tract [24,25]. Here, KEAP1 is linked to Hyperkeratosis.